The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
Abstract
Background: In the earliest clinical stages of Alzheimer's disease (AD) when symptoms are mild, clinical diagnosis can be difficult. AD pathology most likely precedes symptoms. Biomarkers can serve as early diagnostic indicators or as markers of preclinical pathologic change. Candidate biomarkers derived from structural and functional neuroimaging and those measured in cerebrospinal fluid (CSF) and plasma show the greatest promise. Unbiased exploratory approaches, eg, proteomics or cortical thickness analysis, could yield novel biomarkers. The objective of this article was to review recent progress in selected imaging and neurochemical biomarkers for early diagnosis, classification, progression, and prediction of AD. Methods: We performed a survey of recent research, focusing on core biomarker candidates in AD. Results: A number of in vivo neurochemistry and neuroimaging techniques, which can reliably assess aspects of physiology, pathology, chemistry, and neuroanatomy, hold promise as biomarkers. These neurobiologic measures appear to relate closely to pathophysiologic, neuropathologic, and clinical data, such as hyperphosphorylation of tau, amyloid beta (Aβ) metabolism, lipid peroxidation, pattern and rate of atrophy, loss of neuronal integrity, functional and cognitive decline, as well as risk of future decline. Current advances in the neuroimaging of mediotemporal, neocortical, and subcortical areas of the brain of mild cognitive impairment (MCI) and AD subjects are presented. CSF levels of Aβ42, tau, and hyperphosphorylated tau protein (p‐tau) can distinguish subjects with MCI who are likely to progress to AD. They also show preclinical alterations that predict later development of early AD symptoms. Studies on plasma Aβ are not entirely consistent, but recent findings suggest that decreased plasma Aβ42 relative to Aβ40 might increase the risk of AD. Increased production of Aβ in aging is suggested by elevation of BACE1 protein and enzyme activity in the brain and CSF of subjects with MCI. CSF tau and p‐tau are increased in MCI as well and show predictive value. Other biomarkers might indicate components of a cascade initiated by Aβ, such as oxidative stress or inflammation. These merit further study in MCI and earlier. Conclusions: A number of neuroimaging candidate markers are promising, such as hippocampus and entorhinal cortex volumes, basal forebrain nuclei, cortical thickness, deformation‐based and voxel‐based morphometry, structural and effective connectivity by using diffusion tensor imaging, tractography, and functional magnetic resonance imaging. CSF Aβ42, BACE1, total tau, and p‐tau are substantially altered in MCI and clinical AD. Other interesting novel marker candidates derived from blood are being currently proposed (phase I). Biomarker discovery through proteomic approaches requires further research. Large‐scale international controlled multicenter trials (such as the U.S., European, Australian, and Japanese Alzheimer's Disease Neuroimaging Initiative and the German Dementia Network) are engaged in phase III development of the core feasible imaging and CSF biomarker candidates in AD. Biomarkers are in the process of implementation as primary outcome variables into regulatory guideline documents regarding study design and approval for compounds claiming disease modification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Self-citationGreicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., Wallin, A., Ader, H., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Self-citationPrediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
Self-citationInverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246
Functional Magnetic Resonance Imaging
(2014) · Encyclopedia of Criminal Justice Ethics · doi:10.4135/9781452274102.n135 · Cited by 1,225
Alzheimer’s Dementia: Dilemmas in Clinical Research
(1985) · Humana Press eBooks · doi:10.1007/978-1-4612-5174-3 · Cited by 981
Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.noc60123 · Cited by 897
Celone, K. A., Calhoun, V. D., Dickerson, B. C., Atri, A., Chua, E. F., Miller, S. L., DePeau, K., Rentz, D. M., Selkoe, D. J., Blacker, D., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2250-06.2006 · Cited by 753
Rombouts, S. A. R. B., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005) · Human Brain Mapping · doi:10.1002/hbm.20160 · Cited by 734
Du, A. T. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.441 · Cited by 729
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724
Self-citationIn Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease
Baron, J. C., Chételat, G., Desgranges, B., Perchey, G., Landeau, B., de la Sayette, V., & Eustache, F. (2001) · NeuroImage · doi:10.1006/nimg.2001.0848 · Cited by 684
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1998) · Neurology · doi:10.1212/wnl.51.4.993 · Cited by 666
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
(1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 666
Hippocampus and entorhinal cortex in mild cognitive impairment and early AD
Pennanen, C., Kivipelto, M., Tuomainen, S., Hartikainen, P., Hänninen, T., Laakso, M. P., Hallikainen, M., Vanhanen, M., Nissinen, A., Helkala, E.-L., et al. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00084-8 · Cited by 643
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease
Karas, G. B., Scheltens, P., Rombouts, S. A. R. B., Visser, P. J., van Schijndel, R. A., Fox, N. C., & Barkhof, F. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.006 · Cited by 613
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
Strozyk, D., Blennow, K., White, L. R., & Launer, L. J. (2003) · Neurology · doi:10.1212/01.wnl.0000046581.81650.d0 · Cited by 612
Self-citationBuerger, K., Ewers, M., Pirttila, T., Zinkowski, R., Alafuzoff, I., Teipel, S. J., DeBernardis, J., Kerkman, D., McCulloch, C., Soininen, H., et al. (2006) · Brain · doi:10.1093/brain/awl269 · Cited by 586
Self-citationEffects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Fox, N. C., Black, R. S., Gilman, S., Rossor, M. N., Griffith, S. G., Jenkins, L., & Koller, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159743.08996.99 · Cited by 550
Chételat, G., Landeau, B., Eustache, F., Mézenge, F., Viader, F., de la Sayette, V., Desgranges, B., & Baron, J.-C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.015 · Cited by 526
Morris, J. C., & Price, J. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:101 · Cited by 513
Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study
van Oijen, M., Hofman, A., Soares, H. D., Koudstaal, P. J., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70501-4 · Cited by 458
Graff-Radford, N. R., Crook, J. E., Lucas, J., Boeve, B. F., Knopman, D. S., Ivnik, R. J., Smith, G. E., Younkin, L. H., Petersen, R. C., & Younkin, S. G. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.354 · Cited by 441
Sjögren, M., Vanderstichele, H., Ågren, H., Zachrisson, O., Edsbagge, M., Wikkelsø, C., Skoog, I., Wallin, A., Wahlund, L.-O., Marcusson, J., et al. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1776 · Cited by 436
Self-citationHampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.95 · Cited by 434
Self-citationPlasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk
Mayeux, R., Honig, L. S., Tang, M.-X., Manly, J., Stern, Y., Schupf, N., & Mehta, P. D. (2003) · Neurology · doi:10.1212/01.wnl.0000091890.32140.8f · Cited by 434
Focal Decline of Cortical Thickness in Alzheimer's Disease Identified by Computational Neuroanatomy
Lerch, J. P., Pruessner, J. C., Zijdenbos, A., Hampel, H., Teipel, S. J., & Evans, A. C. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhh200 · Cited by 431
Self-citationDifferential aging of the medial temporal lobe: A study of a five-year change
Raz, N., Rodrigue, K. M., Head, D., Kennedy, K. M., & Acker, J. D. (2004) · Neurology · doi:10.1212/01.wnl.0000106466.09835.46 · Cited by 427
Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment
Ch??telat, G., Desgranges, B., de la Sayette, V., Viader, F., Eustache, F., & Baron, J.-C. (2002) · NeuroReport · doi:10.1097/00001756-200210280-00022 · Cited by 410
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD
de Leon, M., Bobinski, M., Convit, A., Wolf, O., & Insausti, R. (2001) · Neurology · doi:10.1212/wnl.56.6.820 · Cited by 348
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD
Xu, Y., Jack, C. R., O’Brien, P. C., Kokmen, E., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, R. G., & Petersen, R. C. (2000) · Neurology · doi:10.1212/wnl.54.9.1760 · Cited by 336
Csernansky, J. G., Wang, L., Swank, J., Miller, J. P., Gado, M., McKeel, D., Miller, M. I., & Morris, J. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.12.036 · Cited by 328
Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
Vanderstichele, H., Kerschaver, E. V., Hesse, C., Davidsson, P., Buyse, M.-A., Andreasen, N., Minthon, L., Wallin, A., Blennow, K., & Vanmechelen, E. (2000) · Amyloid · doi:10.3109/13506120009146438 · Cited by 301
Self-citationHampel, H., Teipel, S. J., Fuchsberger, T., Andreasen, N., Wiltfang, J., Otto, M., Shen, Y., Dodel, R., Du, Y., Farlow, M., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001473 · Cited by 287
Self-citationLerch, J. P., Pruessner, J., Zijdenbos, A. P., Collins, D. L., Teipel, S. J., Hampel, H., & Evans, A. C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.013 · Cited by 281
Self-citationBuerger, K., Zinkowski, R., Teipel, S. J., Tapiola, T., Arai, H., Blennow, K., Andreasen, N., Hofmann-Kiefer, K., DeBernardis, J., Kerkman, D., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.8.1267 · Cited by 277
Self-citationBiomarkers of Alzheimer disease in plasma
Irizarry, M. C. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.226 · Cited by 268
Wiltfang, J., Esselmann, H., Bibl, M., Hüll, M., Hampel, H., Kessler, H., Frölich, L., Schröder, J., Peters, O., Jessen, F., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04404.x · Cited by 263
Self-citationBokde, A. L. W., Lopez-Bayo, P., Meindl, T., Pechler, S., Born, C., Faltraco, F., Teipel, S. J., Möller, H.-J., & Hampel, H. (2006) · Brain · doi:10.1093/brain/awl051 · Cited by 260
Self-citationFluctuations of CSF amyloid-β levels: Implications for a diagnostic and therapeutic biomarker
Bateman, R. J., Wen, G., Morris, J. C., & Holtzman, D. M. (2007) · Neurology · doi:10.1212/01.wnl.0000256043.50901.e3 · Cited by 260
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
de Leon, M. J., DeSanti, S., Zinkowski, R., Mehta, P. D., Pratico, D., Segal, S., Rusinek, H., Li, J., Tsui, W., Saint Louis, L. A., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.003 · Cited by 253
Self-citationBiological markers for therapeutic trials in Alzheimer’s disease
Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252
Self-citationMeasurement of basal forebrain atrophy in Alzheimer's disease using MRI
Teipel, S. J., Flatz, W. H., Heinsen, H., Bokde, A. L. W., Schoenberg, S. O., Stöckel, S., Dietrich, O., Reiser, M. F., Möller, H.-J., & Hampel, H. (2005) · Brain · doi:10.1093/brain/awh589 · Cited by 248
Self-citationMehta, P. D., Pirttila, T., Patrick, B. A., Barshatzky, M., & Mehta, S. P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01754-2 · Cited by 231
A voxel based morphometry study on mild cognitive impairment
Pennanen, C. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.035600 · Cited by 219
A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease
Busatto, G. F., Garrido, G. E. J., Almeida, O. P., Castro, C. C., Camargo, C. H. P., Cid, C. G., Buchpiguel, C. A., Furuie, S., & Bottino, C. M. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00084-2 · Cited by 218
Stahl, R., Dietrich, O., Teipel, S. J., Hampel, H., Reiser, M. F., & Schoenberg, S. O. (2007) · Radiology · doi:10.1148/radiol.2432051714 · Cited by 216
Self-citationComparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia
Hsu, Y., Schuff, N., Du, A., Mark, K., Zhu, X., Hardin, D., & Weiner, M. W. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10163 · Cited by 215
Krasuski, J. S., Alexander, G. E., Horwitz, B., Daly, E. M., Murphy, D. G. M., Rapoport, S. I., & Schapiro, M. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00013-9 · Cited by 211
Zhong, Z., Ewers, M., Teipel, S., Bürger, K., Wallin, A., Blennow, K., He, P., McAllister, C., Hampel, H., & Shen, Y. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.718 · Cited by 206
Self-citationTeipel, S. J., Born, C., Ewers, M., Bokde, A. L. W., Reiser, M. F., Möller, H.-J., & Hampel, H. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.008 · Cited by 202
Self-citationPlasma Aβ in Alzheimer's disease—up or down?
Zetterberg, H., & Blennow, K. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70503-8 · Cited by 200
Self-citationCSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
Buerger, K., Teipel, S. J., Zinkowski, R., Blennow, K., Arai, H., Engel, R., Hofmann–Kiefer, K., McCulloch, C., Ptok, U., Heun, R., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.627 · Cited by 187
Self-citationTeipel, S. J., Alexander, G. E., Schapiro, M. B., Möller, H., Rapoport, S. I., & Hampel, H. J. (2004) · Brain · doi:10.1093/brain/awh101 · Cited by 185
Self-citationHigh Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease
Kuo, Y.-M., Emmerling, M. R., Lampert, H. C., Hempelman, S. R., Kokjohn, T. A., Woods, A. S., Cotter, R. J., & Roher, A. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0552 · Cited by 182
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment
Bouwman, F. H., Schoonenboom, S. N. M., van der Flier, W. M., van Elk, E. J., Kok, A., Barkhof, F., Blankenstein, M. A., & Scheltens, P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.006 · Cited by 177
Hampel, H., Bürger, K., Pruessner, J. C., Zinkowski, R., DeBernardis, J., Kerkman, D., Leinsinger, G., Evans, A. C., Davies, P., Möller, H.-J., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.770 · Cited by 175
Self-citationMultivariate network analysis of fiber tract integrity in Alzheimer’s disease
Teipel, S. J., Stahl, R., Dietrich, O., Schoenberg, S. O., Perneczky, R., Bokde, A. L. W., Reiser, M. F., Möller, H.-J., & Hampel, H. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.07.047 · Cited by 170
Self-citationMulticenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
Ewers, M., Büerger, K., Teipel, S. J., Scheltens, P., Schröder, J., Zinkowski, R. P., Bouwman, F. H., Schönknecht, P., Schoonenboom, N. S. M., Andreasen, N. C., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000286944.22262.ff · Cited by 161
Self-citationBohnen, N. I. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.038729 · Cited by 160
Neuroanatomy of Down Syndrome in vivo: A Model of Preclinical Alzheimer’s Disease
Teipel, S. J., & Hampel, H. J. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9047-x · Cited by 159
Self-citationBrain metabolic and clinical effects of rivastigmine in Alzheimer's disease
Potkin, S. G., Anand, R., Fleming, K., Alva, G., Keator, D., Carreon, D., Messina, J., Wu, J. C., Hartman, R., & Fallon, J. H. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002528 · Cited by 158
Kapaki, E., Paraskevas, G. P., Tzerakis, N. G., Sfagos, C., Seretis, A., Kararizou, E., & Vassilopoulos, D. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01593.x · Cited by 154
Herholz, K., Weisenbach, S., Zündorf, G., Lenz, O., Schröder, H. C., Bauer, B., Kalbe, E., & Wd, H. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.09.042 · Cited by 137
Hippocampus in Alzheimer’s disease: a 3-year follow-up MRI study
Laakso, M. P., Lehtovirta, M., Partanen, K. P. L., Riekkinen, P. J., & Soininen, H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00167-5 · Cited by 136
An Alzheimer's disease-specific β-amyloid fragment signature in cerebrospinal fluid
Portelius, E., Zetterberg, H., Andréasson, U., Brinkmalm, G., Andreasen, N., Wallin, A., Brinkmalm, A., & Blennow, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.044 · Cited by 134
Self-citationTeipel, S. J., Pruessner, J. C., Faltraco, F., Born, C., Rocha-Unold, M., Evans, A. C., Möller, H. ‐., & Hampel, H. J. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0120-4 · Cited by 130
Self-citationInvestigating the neural basis for functional and effective connectivity. Application to fMRI
Horwitz, B., Warner, B. T., Fitzer, J., Tagamets, M.-A., Husain, F. T., & Long, T. W. (2005) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1647 · Cited by 120
Gilman, S., Koeppe, R. A., Little, R. J. A., An, H., Junck, L., Giordani, B., Persad, C. C., Heumann, M., & Wernette, K. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.06.017 · Cited by 112
Modrego, P. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506776383103 · Cited by 104
Multicenter assessment of reliability of cranial MRI
Ewers, M., Teipel, S. J., Dietrich, O., Schönberg, S., Jessen, F., Heun, R., Scheltens, P., van de Pol, L. A., Freymann, N., Moeller, H. –., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.032 · Cited by 100
Self-citationPomara, N., Willoughby, L. M., Sidtis, J. J., & Mehta, P. D. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.10.914 · Cited by 99
de Jong, D., Jansen, R. W. M. M., Kremer, B. P. H., & Verbeek, M. M. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.7.755 · Cited by 98
Lewczuk, P., Kornhuber, J., Vanderstichele, H., Vanmechelen, E., Esselmann, H., Bibl, M., Wolf, S., Otto, M., Reulbach, U., Kölsch, H., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.010 · Cited by 97
Self-citationBack to the future: the 'old-fashioned' way to new medications for neurodegeneration
Lansbury, P. T. (2004) · Nature Medicine · doi:10.1038/nrn1435 · Cited by 92
β‐amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Wiltfang, J., Esselmann, H., Av, S., Bibl, M., Cepek, L., Steinacker, P., Mollenhauer, B., Büerger, K., Hampel, H. J., Paul, S., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10661 · Cited by 91
Self-citationSydykova, D., Stahl, R., Dietrich, O., Ewers, M., Reiser, M. F., Schoenberg, S. O., Möller, H. ‐., Hampel, H. J., & Teipel, S. J. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl136 · Cited by 87
Self-citationHansson, O., Buchhave, P., Zetterberg, H., Blennow, K., Minthon, L., & Warkentin, S. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.009 · Cited by 83
Self-citationPlasma Aβ Levels Do Not Reflect Brain Aβ Levels
Freeman, S. H., Raju, S., Hyman, B. T., Frosch, M. P., & Irizarry, M. C. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31803d3ae4 · Cited by 78
Teipel, S. J., Drzezga, A. E., Bartenstein, P., Möller, H., Schwaiger, M., & Hampel, H. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0408-1 · Cited by 78
Self-citationBuch, K., Padberg, F., Nolde, T., Teipel, S. J., Stübner, S., Haslinger, A., Schwarz, M., Sunderland, T., Arai, H., Rapoport, S. I., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00845-9 · Cited by 76
Self-citationPrediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan
Wang, P. N., Lirng, J. F., Lin, K. N., Chang, F., & Liu, H. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.002 · Cited by 75
Imaging Alzheimer's disease: clinical applications
Minoshima, S. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00099-6 · Cited by 69
Phosphorylated tau predicts rate of cognitive decline in MCI subjects: A comparative CSF study
Büerger, K., Ewers, M., Andreasen, N. C., Zinkowski, R. P., Ishiguro, K., Vanmechelen, E., Teipel, S. J., Graz, C., Blennow, K., & Hampel, H. J. (2005) · Neurology · doi:10.1212/01.wnl.0000183284.92920.f2 · Cited by 66
Self-citationSpillantini, M. G., Goedert, M., Jakes, R., & Klug, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3952 · Cited by 62
Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
Ikeda, S., Yanagisawa, N., Allsop, D., & Glenner, G. G. (1989) · PubMed · Cited by 61
Biochemistry and molecular biology of tauopathies
Hasegawa, M. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00666.x · Cited by 57
Büerger, K., Alafuzoff, I. I., Ewers, M., Pirttilä, T., Zinkowski, R. P., & Hampel, H. J. (2007) · Brain · doi:10.1093/brain/awm140 · Cited by 56
Self-citationTeipel, S., Bokde, A. L. W., Born, C., Meindl, T., Reiser, M. F., Møller, H. J., & Hampel, H. J. (2007) · Brain · doi:10.1093/brain/awm117 · Cited by 52
Self-citationImaging of Muscarinic Receptors in the Central Nervous System
Eckelman, W. C. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778559678 · Cited by 40
CSF phosphorylated tau—does it constitute an accurate biological test for Alzheimer's disease?
Mitchell, A. J., & Brindle, N. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.845 · Cited by 34
Cited by
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Self-citationAlzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Current understanding of Alzheimer’s disease diagnosis and treatment
Weller, J., & Budson, A. (2018) · F1000Research · doi:10.12688/f1000research.14506.1 · Cited by 1,083
Metadata
- Authors
- Hampel, H., Bürger, K., Teipel, S. J., Bokde, A. L. W., Zetterberg, H., & Blennow, K.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2007-12-21
- Volume
- 4
- Issue
- 1
- Pages
- 38-48
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2013391120
- Cited by
- 532
- References
- 97
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.